September 19, 2025

EADV data shows Ilumetri’s ‘significant value in long-term holistic management of psoriasis’ – The Pharma Letter

September 19, 2025

Bimekizumab Effective in Bio-Naïve, Bio-Experienced Patients with Psoriasis – HCPLive

September 19, 2025

Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era – FinancialContent

September 19, 2025

Once-Daily Pill for Psoriasis Gets High Marks in Multiple Studies – MedPage Today

September 19, 2025

Risankizumab and Treatment Sequencing in Scalp and Genital Psoriasis, With Eingun James Song, MD – HCPLive